First ever drug to slow Alzheimer鈥檚 is approved in US but experts warn caution
8 June 2021
Aducanumab, a new Alzheimer鈥檚 drug, has been given the green light, but Professor John Hardy (UCL Queen Square Institute of Neurology) says it 鈥渨ill help only very carefully selected patients鈥� and Professor Robert Howard (UCL Psychiatry) says it 鈥渞epresents a grave error鈥�.
Close
